Once Weekly Selinexor, Bortezomib, and Dexamethasone Versus Twice Weekly Bortezomib and Dexamethasone in Relapsed or Refractory Multiple Myeloma: Age and Frailty Subgroup Analyses from the Phase 3 Boston Study - Auner, HW; Gavriatopoulou, M; Delimpasi, S; Simonova, M; Spicka, I; Pour, L; Dimopoulos, MA; Kryachok, I; Pylypenko, H; Leleu, X; Doronin, VA; Usenko, G; et al. (AMER SOC HEMATOLOGY, 2020)